FDA Approves Moderna RSV Vaccine, an mRNA Alternative to GSK and Pfizer Products
Moderna’s messenger RNA vaccine for respiratory syncytial virus (RSV) is now FDA approved, a regulatory decision that comes nearly a year after GSK and Pfizer won regulatory approvals for their vaccines to prevent infection from the seasonal respiratory …